Mode
Text Size
Log in / Sign up
N/A N=78 Randomized Double-blind Screening

HIV-Related Stigma Intervention for Malaysian Clinicians

Hiv

Enrolled (actual)
78
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Acceptability of Intervention — 4.22; 4.72; 4.45 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
HIV Connect (Behavioral); Project ECHO for HIV Prevention (Behavioral); Project ECHO for HIV Prevention and Stigma Reduction (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Delaware
Primary completion
Mar 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Acceptability of Intervention
4.22; 4.72; 4.45
PRIMARY
Feasibility of Intervention
4.22; 4.62; 4.32
PRIMARY
Stigma Reduction: Prejudice
29.13; 23.28; 32.07
PRIMARY
Stigma Reduction: Stereotypes
2.55; 2.01; 2.32
PRIMARY
Stigma Reduction: Discrimination
4.44; 4.67; 4.64
SECONDARY
HIV Prevention Procedures: HIV Testing
21.54; 2.65; 10.46
SECONDARY
HIV Prevention Procedures: PrEP Prescriptions
2.04; 0.07; 0.11

Summary

Key populations at risk of HIV (including men who have sex with men, people who inject drugs, transgender women, and female sex workers) are more likely to be infected with HIV but less likely than members of the general population to know of their HIV status, receive HIV prevention counseling, or be linked to HIV care services. Clinician stigma towards these groups remains a potent and persistent driver of these HIV disparities in many places of the world. The investigators propose to incorporate evidence-based stigma reduction tools into a popular teletraining platform for clinicians and pilot test the resulting intervention (Project ECHO® for HIV Prevention and Stigma Reduction) with clinicians in Malaysia, a context wherein clinician stigma and HIV disparities are substantial.

Eligibility Criteria

Inclusion Criteria

  • practicing general practitioner or family medicine specialist in Malaysia

Exclusion Criteria

-

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05597787). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search